Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» remdesivir
remdesivir
WHO's decision to reject remdesivir based on flawed study, health experts say
Beckers Hospital Review
Thu, 12/3/20 - 10:44 pm
WHO
Gilead Sciences
remdesivir
COVID-19
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
Motley Fool
Sun, 11/29/20 - 02:20 pm
Gilead Sciences
COVID-19
remdesivir
Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus remdesivir combo
Endpoints
Thu, 11/19/20 - 11:09 pm
Eli Lilly
FDA
COVID-19
Emergency Use Authorization
olumiant
remdesivir
WHO group recommends against using remdesivir to treat hospitalized Covid-19 patients
Stat
Thu, 11/19/20 - 08:31 pm
WHO
Gilead Sciences
remdesivir
COVID-19
Veklury
After WHO trial failure, influential medical group advises against Gilead's remdesivir in COVID critical care: Reuters
Fierce Pharma
Fri, 11/13/20 - 01:28 pm
Gilead Sciences
remdesivir
Veklury
COVID-19
Will Gilead's Remdesivir Only Be a Short-Lived Success Story?
Motley Fool
Wed, 11/4/20 - 10:16 am
Gilead Sciences
remdesivir
COVID-19
Veklury
Gilead should give up FDA voucher for remdesivir, patient advocates say
Beckers Hospital Review
Tue, 11/3/20 - 09:32 pm
Gilead Sciences
remdesivir
FDA
Public Citizen
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Motley Fool
Wed, 10/28/20 - 11:15 pm
Gilead Sciences
earnings
Veklury
remdesivir
COVID-19
WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
Reuters
Sun, 10/25/20 - 11:26 pm
Gilead Sciences
remdesivir
WHO
clinical trials
COVID-19
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Motley Fool
Thu, 10/22/20 - 11:29 pm
Gilead Sciences
remdesivir
FDA
COVID-19
Smaller biotech firms continue to bring new approaches against COVID-19 complications
Biotechblog
Thu, 10/22/20 - 11:04 pm
COVID-19
remdesivir
hydroxychloroquine
Lopinavir
interferon
WHO
FSD Pharma
Q Biomed
Aqualung Pharmaceuticals
Massive Covid-19 Drug Trial Underscores Importance Of Controlled Clinical Studies
Forbes
Tue, 10/20/20 - 10:00 pm
WHO
clinical trials
COVID-19
remdesivir
Gilead Sciences
interferon
WHO: Remdesivir Does Not Substantially Affect COVID-19 Patient Mortality
Motley Fool
Fri, 10/16/20 - 11:16 am
Gilead Sciences
remdesivir
Veklury
COVID-19
clinical trials
EU makes 1 billion-euro bet on Gilead's COVID drug before trial results
Reuters
Tue, 10/13/20 - 10:00 pm
Europe
Gilead Sciences
COVID-19
remdesivir
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Yahoo/Reuters
Fri, 10/9/20 - 11:08 am
Gilead Sciences
remdesivir
FDA
COVID-19
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Fri, 10/9/20 - 10:52 am
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
European Medicines Agency reviewing reports of kidney injury in patients taking Gilead's remdesivir
Beckers Hospital Review
Mon, 10/5/20 - 11:55 pm
EMA
Europe
Gilead Sciences
remdesivir
COVID-19
President Trump Begins Treatment With Remdesivir from Gilead Sciences
Motley Fool
Sun, 10/4/20 - 12:21 am
Donald Trump
COVID-19
Gilead Sciences
remdesivir
Veklury
Gilead to distribute COVID-19 drug Veklury in US, taking over from federal government
BioPharma Dive
Fri, 10/2/20 - 01:06 pm
Gilead Sciences
remdesivir
Veklury
COVID-19
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Stat
Thu, 09/17/20 - 11:15 pm
Gilead Sciences
remdesivir
COVID-19
profits
drug pricing
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »